Ozanimod clinical trials

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

This study is testing a new medicine, ozanimod, for children aged 2-17 with moderate to severe ulcerative colitis that hasn't responded well to other treatments. We want to see if it helps them feel better and stay well.